132 related articles for article (PubMed ID: 18946937)
1. Pretreatment tumor diameter/volume and pelvic lymph node status assessed by magnetic resonance imaging for uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim HJ; Kim WC
J Obstet Gynaecol Res; 2008 Aug; 34(4):529-37. PubMed ID: 18946937
[TBL] [Abstract][Full Text] [Related]
2. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim H; Kim W; Lee M; Song E; Loh JJ
Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
[TBL] [Abstract][Full Text] [Related]
3. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation.
Toita T; Kakinohana Y; Shinzato S; Ogawa K; Yoshinaga M; Iraha S; Higashi M; Sakumoto K; Kanazawa K; Sawada S
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):777-82. PubMed ID: 10098432
[TBL] [Abstract][Full Text] [Related]
4. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice.
Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana K; Furutani K; Ogawa K
Am J Clin Oncol; 2003 Dec; 26(6):574-83. PubMed ID: 14663375
[TBL] [Abstract][Full Text] [Related]
7. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?
Kodaira T; Fuwa N; Kamata M; Furutani K; Kuzuya K; Ogawa K; Toita T; Sasaoka M; Nomoto Y
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):627-36. PubMed ID: 11849783
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy.
Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana H; Furutani K; Ogawa K
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):769-77. PubMed ID: 12788184
[TBL] [Abstract][Full Text] [Related]
11. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
13. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
18. Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: Patterns of failure and outcomes in a contemporary population.
Lapuz C; Kondalsamy-Chennakesavan S; Bernshaw D; Khaw P; Narayan K
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):274-82. PubMed ID: 26549207
[TBL] [Abstract][Full Text] [Related]
19. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
20. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
